HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Gianpietro Dotti Selected Research
Gianpietro Dotti Research Topics
Disease
126
Neoplasms (Cancer)
03/2022 - 07/2002
12
Neuroblastoma
11/2020 - 11/2008
10
Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 09/2008
10
Graft vs Host Disease (Graft-Versus-Host Disease)
04/2016 - 11/2003
9
Lymphoma (Lymphomas)
11/2021 - 10/2002
8
Melanoma (Melanoma, Malignant)
01/2022 - 09/2008
8
Leukemia
01/2016 - 02/2003
7
Hodgkin Disease (Hodgkin's Disease)
01/2022 - 10/2007
7
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2021 - 04/2003
7
Glioblastoma (Glioblastoma Multiforme)
10/2021 - 01/2016
5
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 11/2013
4
Multiple Myeloma
03/2019 - 01/2002
4
Infections
06/2015 - 10/2002
3
Lung Neoplasms (Lung Cancer)
01/2022 - 01/2018
3
Brain Neoplasms (Brain Tumor)
01/2022 - 12/2011
3
Neoplasm Metastasis (Metastasis)
01/2021 - 01/2018
3
Sarcoma (Soft Tissue Sarcoma)
12/2020 - 05/2015
3
Breast Neoplasms (Breast Cancer)
01/2020 - 06/2007
3
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 11/2014
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2019 - 01/2019
2
Hyperthermia
06/2019 - 06/2015
2
Cytokine Release Syndrome
12/2018 - 06/2015
2
Glioma (Gliomas)
01/2017 - 02/2016
2
Virus Diseases (Viral Diseases)
10/2013 - 08/2009
2
Persistent Infection
12/2011 - 07/2011
2
B-Cell Lymphoma (Lymphoma, B Cell)
05/2011 - 12/2006
2
Testicular Neoplasms (Testicular Cancer)
03/2011 - 09/2008
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2008 - 12/2006
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022
1
Osteosarcoma (Osteogenic Sarcoma)
01/2022
Drug/Important Bio-Agent (IBA)
81
Chimeric Antigen Receptors
IBA
03/2022 - 11/2005
46
Antigens
IBA
01/2022 - 07/2002
11
Cytokines
IBA
11/2021 - 10/2007
11
Interleukin-15 (Interleukin 15)
IBA
01/2021 - 10/2007
9
Neoplasm Antigens (Tumor Antigens)
IBA
01/2022 - 04/2003
8
Interleukin-2 (IL2)
IBA
06/2014 - 10/2005
7
Monoclonal Antibodies
IBA
01/2020 - 03/2005
6
Vaccines
IBA
01/2019 - 04/2003
5
CD40 Ligand (CD40L)
IBA
10/2011 - 07/2002
4
chondroitin sulfate proteoglycan 4
IBA
01/2021 - 01/2015
4
Pharmaceutical Preparations
IBA
12/2020 - 11/2011
4
Cyclophosphamide (Cytoxan)
FDA Link
Generic
12/2018 - 06/2015
4
Proteins (Proteins, Gene)
FDA Link
05/2015 - 04/2003
3
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2022 - 01/2015
3
Ki-1 Antigen
IBA
01/2022 - 06/2009
3
Immunoglobulins (Immunoglobulin)
IBA
11/2021 - 10/2005
3
B7-H1 Antigen
IBA
01/2021 - 01/2018
3
fludarabine
IBA
11/2020 - 06/2015
3
GD2 ganglioside
IBA
10/2020 - 09/2009
3
ErbB Receptors (EGF Receptor)
IBA
01/2020 - 12/2011
3
Immune Checkpoint Inhibitors
IBA
01/2020 - 01/2018
3
Epitopes
IBA
01/2019 - 04/2012
3
Chemokines
IBA
01/2018 - 06/2009
3
Therapeutic Uses
IBA
01/2018 - 08/2010
3
AP 1903 reagent
IBA
04/2016 - 11/2011
3
Caspase 9
IBA
04/2016 - 11/2014
3
CD19-specific chimeric antigen receptor
IBA
01/2016 - 10/2013
3
Interleukin-7 (Interleukin 7)
IBA
06/2014 - 05/2009
2
Interleukin-12 (IL 12)
IBA
01/2022 - 01/2018
2
Interferons
IBA
01/2022 - 12/2021
2
Fibrin
IBA
10/2021 - 01/2019
2
Hydrogels
IBA
01/2021 - 10/2020
2
vadimezan
IBA
01/2021 - 01/2021
2
Cancer Vaccines
IBA
12/2020 - 01/2019
2
Doxorubicin (Adriamycin)
FDA Link
Generic
12/2020 - 01/2018
2
Interleukins
IBA
10/2020 - 01/2013
2
Panitumumab (Vectibix)
FDA Link
01/2020 - 01/2020
2
Interferon-gamma (Interferon, gamma)
IBA
01/2020 - 11/2005
2
Cetuximab (Erbitux)
FDA Link
01/2020 - 01/2020
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2020 - 01/2018
2
Chondroitin Sulfates (Chondroitin Sulfate)
IBA
06/2019 - 02/2014
2
Antibodies
IBA
01/2019 - 10/2014
2
Transforming Growth Factors (Transforming Growth Factor)
IBA
10/2018 - 06/2008
2
CD19 Antigens
IBA
01/2017 - 05/2011
2
human ERBB2 protein
IBA
05/2015 - 06/2007
2
Chemokine CCL5
IBA
02/2015 - 09/2014
2
Autoantigens
IBA
01/2015 - 07/2002
2
Biological Products
IBA
09/2014 - 11/2012
2
Viral Antigens
IBA
10/2013 - 12/2011
2
Antiviral Agents (Antivirals)
IBA
10/2013 - 04/2010
2
Ligands
IBA
06/2009 - 03/2005
1
Vimentin
IBA
01/2022
1
CCR2 Receptors
IBA
01/2022
1
Enhancer of Zeste Homolog 2 Protein
IBA
01/2022
1
Antineoplastic Agents (Antineoplastics)
IBA
01/2022
1
tazemetostat
IBA
01/2022
1
Adenosine Triphosphate (ATP)
IBA
12/2021
1
Immunoglobulin Light Chains (Immunoglobulin Light Chain)
IBA
11/2021
Therapy/Procedure
48
Immunotherapy
01/2021 - 07/2002
46
Therapeutics
03/2022 - 03/2005
6
Drug Therapy (Chemotherapy)
12/2019 - 10/2002
5
Transplantation
11/2015 - 11/2003
5
Stem Cell Transplantation
11/2011 - 08/2007
4
Hematopoietic Stem Cell Transplantation
11/2015 - 11/2003
2
Cell- and Tissue-Based Therapy (Cell Therapy)
01/2022 - 12/2021
2
Intravenous Infusions
01/2022 - 07/2009
2
Intravenous Administration
10/2021 - 01/2021
2
Radiotherapy
01/2021 - 10/2014
2
Injections
10/2020 - 10/2014
1
Transjugular Intrahepatic Portasystemic Shunt
03/2022